Andromeda Metals Limited (ASX:ADN) has issued a second Supplementary Prospectus dated 10 October 2024, to provide clarity on the offers of Shortfall Securities and the application process. This Supplementary Prospectus is intended to be read with the prospectus dated 27 August 2024 and the First Supplementary Prospectus dated 12 September 2024.
The Company is issuing this Second Supplementary Prospectus to ensure that it is clear that offers of Shortfall Securities are made under a disclosure document and that applications can be made by any persons. This Second Supplementary Prospectus has no impact on the Entitlement Offer, the Top Up Facility, the Option Offer or Broker Option Offer.
Andromeda Metals Limited (ASX:ADN) has issued a second Supplementary Prospectus to clarify the offers of Shortfall Securities and the application process. The amendments to the Prospectus include the explicit reference to the Shortfall Offer, the inclusion of new definitions in the Glossary, and the replacement of section 2.6 of the Prospectus with detailed information on the Shortfall. The Company emphasizes that this Supplementary Prospectus is not financial product advice and does not take into account the investment objectives, financial situation, or particular needs of any investor. It is important for investors to read this Second Supplementary Prospectus carefully and in full. The Directors have authorized the issue of this Supplementary Prospectus, and it has been consented to by each Director in accordance with Section 720 of the Corporations Act. For further information or queries regarding the Shortfall Securities, individuals can contact the Company or the Joint Lead Managers.